• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Clinical Nutrition Products - Global Strategic Business Report Product Image

Clinical Nutrition Products - Global Strategic Business Report

  • ID: 1227821
  • January 2015
  • Region: Global
  • 388 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America.

Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 64 companies including many key and niche players such as:

- Abbott Nutrition
- American HomePatient, Inc.
- Baxter International, Inc.
- B. Braun Melsungen AG
- Claris Lifesciences Ltd.

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
1. Enteral Nutrition
2. Infant Nutrition
3. Parenteral Nutrition

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
A Bird’s Eye View of the Clinical Nutrition Products Market
Emerging Markets: The New Hotspots for Growth
Table 1: GDP Growth for Key Developed and Developing Countries: 2003-2013 (includes corresponding Graph/Chart)
Infant Nutrition: Rapid Growth in Store
Infant Formula Market: Emerging Markets to Drive Growth
Competitive Landscape
Table 2: Leading Players in the Global Clinical Nutrition Market (2013): Percentage Breakdown of Value Sales for Abbott Nutrition, Danone, Fresenius Kabi, Nestle, and Others (includes corresponding Graph/Chart)
Table 3: Leading Players in the Global Infant Formula Market (2013): Percentage Share Breakdown of Volume Sales by Manufacturer (includes corresponding Graph/Chart)
Enteral Nutrition Market
Table 4: Leading Players in the Global Enteral Nutrition Market (2013): Percentage Breakdown of Value Sales for Abbott, Nestle, Danone, Fresenius and Others (includes corresponding Graph/Chart)
Major Players in the Enteral Nutrition and Enteral Infant Nutrition Market
Parenteral Nutrition Market
Table 5: Leading Players in the Global Parenteral Nutrition Market (2013): Percentage Share Breakdown of Value Sales for Baxter International, Fresenius Kabi, B.Braun, Hospira and Others (includes corresponding Graph/Chart)
Leading Players Operating in the Market for Parenteral Nutrition
Select Parenteral Nutrition Products by Company

2. MARKET DRIVERS, TRENDS & ISSUES
Impact of Recession in Retrospect and the Road Ahead
Improving Healthcare Expenditure to Drive Demand
Table 6: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
Table 7: Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
Aging Population: A Strong Growth Driver
Table 8: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
Table 9: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
Table 10: Life Expectancy at Age 60 and 80 Years
(2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
Rising Incidence of Chronic Diseases to Kindle Market Growth
World Cancer Statistics: Incidence and Mortality Data
Table 11: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed
Table 12: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 13: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
Table 14: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
Table 15: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
Table 16: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
Table 17: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
Table 18: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)
Cancer Prone Sites based on Age
Diabetes Mellitus: Another Major Chronic Condition
Table 19: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
Table 20: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)
Table 21: Countries with Highest Number of People with DM (in Millions) among Ages 20-79: 2014E & 2035P (includes corresponding Graph/Chart)
Table 22: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
Table 23: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
Table 24: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
Table 25: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
Table 26: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
Table 27: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
Table 28: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
Parental Nutrition for Diabetes Patients with Non-functional Gastrointestinal Tract
Global HIV Statistics
Table 29: Global Prevalence of HIV Infection in 2013 by Region (in Millions) (includes corresponding Graph/Chart)
Table 30: Newly Infected HIV Population in 2013 by Region (in Thousands) (includes corresponding Graph/Chart)
Table 31: Global HIV Related Deaths in 2013 by Region (in Thousands) (includes corresponding Graph/Chart)
Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
Non-volitional Nutritional Support Therapy
Vital for Combating Malnutrition during Hospitalization
Shift towards Home Care Boosts Demand for Clinical Nutrition Products
Changing Health and Social Care Factors Favor Home Enteral Feeding
Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
Preterm Birth Statistics from WHO
Table 32: Percentage of Preterm Births by Region: 2012) (includes corresponding Graph/Chart)
Table 33: Top Ten Countries with the Highest Number of Preterm Births (2012) (includes corresponding Graph/Chart)
Table 34: Top Ten Countries with the Highest Rates of Preterm Births (per 100 Live Births): 2012 (includes corresponding Graph/Chart)
Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
Product Innovations Blur the Lines between Medicine and Foods
Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market
Specialized Formula Products Inundate the Market
Soy-based Infant Formula Gains Popularity
Pre-mixed IV Solutions: A Step towards Safer Medication Practices
Growing Demand for Low-Cost Parenteral Nutrition Solutions
Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
Infection Control: A Prime Concern in Parenteral Nutrition
Complacency of Hospitals & Worker/Patient Safety: A Key Issue
Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
Rising Preference for Enteral Nutrition
A Threat to Parenteral Nutrition Market
Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
Major Challenges Confronting Medical Nutrition Products’ Marketers
Barriers to Widespread Adoption of Clinical Nutrition Products
Reasons for Not Prescribing Clinical Nutrition Products

3. PRODUCT OVERVIEW
Clinical Nutrition: An Introduction
Diseases Indicating Administering of Clinical Nutrition
Advantages of Clinical Nutrition
Classification of Clinical Nutrition Products
Infant Nutrition Products
Table 35: Nutrient Specifications for Infant Formulas (per 100kcal)
List of Infant Nutrition Products
Types of Infant Nutrition Products
Specialized Milk-Based Formulas
Soy-based Infant Formula
Amino Acid-based Formulas
Probiotic Infant Formulas
Prebiotics in Infant Nutrition
Exempt Infant Formulas
Human Milk Oligosaccharides
Nutrition Products for Preterm Infants
Premature Infant Formula
Transitional Formulas
Human Milk Fortifiers
Metabolic Infant Formulas
Follow-up or Follow-on Formulas
Enteral Administration of Infant Formulas in Neonatal Intensive Care and General Healthcare Settings
Nipple Feeding
Tube Feeding
Enteral Nutrition Products
Table 36: Daily Electrolyte Requirements for Enteral Nutrition
Table 37: Daily Trace Element Requirement for Enteral Nutrition
Table 38: Daily Vitamin Requirements for Enteral Nutrition
Table 39: Daily Trace Element Requirements Enteral Nutrition in Infants
Table 40: Daily Vitamin Requirements for Enteral Nutrition in Infants
Enteral Nutrition by Age
Enteral Nutrition for Patients aged 21 and older
Enteral Nutrition for Patients below 21 Years
Various Types of Enteral Feeding or Tube Feeding
What Constitutes Enteral Nutrition Diets?
Home-Made Diets
Commercial Enteral Formulas
Elemental Formulas
Oligomeric Formulas
Polymeric Formulas
Special Formulas
Pulmonary Formulas
Liver Formulas
Renal Formulas
Diabetes Formulas
Gastrointestinal Dysfunction Formulas
Immuno-modulatory Formulas
Enteral Nutrition in Patients with Acute Renal Failure (ARF)
Table 41: Nutritional Requirements in Patients with ARF
Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure (CRF)
Table 42: Recommendations for Protein Supply in Adult CRF Patients (in g/kgBW/day)
Table 43: Mineral Requirements for Patients with CRF
Enteral Nutrition in Haemodialysis Patients
Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients
Table 44: Recommendations for Protein and Energy Supply in Adult Patients on Routine Hemodialysis and CAPD
Table 45: Mineral Requirements of Patients on Haemodialysis and Chronic Ambulatory Peritoneal Dialysis
Complications of Enteral Feeding
Complications Associated with Enteral Tube Feeding
Parenteral Nutrition
Sources of Parenteral Solutions
Routes of Administration
Types of Parenteral Nutrition Solutions
Total Parenteral Nutrition (TPN)
Table 46: Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
Table 47: Daily Recommended Parenteral Nutritional Intakes for Newborns
TPN Formulation
Partial Parenteral Nutrition (PPN)
Home Parenteral Nutrition
Parenteral Nutrition Formulations
Standard Solutions
Three-in-One Standard Bags
Two-in-one Standard Bags
Individual Solutions
Non-Standard Solutions
Classification of Parenteral Nutrition by Type of Nutrients
Amino Acids
Carbohydrates
Lipids
Minerals & Electrolytes
Table 48: Daily Electrolyte Requirements for Parenteral Nutrition
Micronutrients
Vitamins
Table 49: Daily Vitamin Requirements for Parenteral Nutrition
Trace Elements
Table 50: Daily Trace Element Requirement for Parenteral Nutrition
Large and Small Volume Parenteral Solutions
Large Volume Parenteral (LVP) Solutions
Small Volume Parenteral (SVP) Solutions
IV Fat Emulsions
Enabling Maintenance of Bodyweight

4. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS
Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product
Alaska Introduces Friso 4 Infant Formula
Fresenius Kabi Obtains FDA Approval for Perikabiven® and Kabiven®
B. Braun Obtains FDA Approval for Nutrilipid® 20% for Parenteral Nutrition
Ingredion Europe Introduces UNI-PURE IMF 2332 and UNI-PURE IMF 8561 Infant Nutrition Product
Fonterra China to Launch Self-Branded Infant Formula in China
FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
Marck Biosciences Receives MCC Approval for Six Pharma Products
Restore Health Pharmacy Launches High Quality Nutritional Supplement
Inergetics Introduces Surgex Ready to Drink Nutritional Beverage
Arla Foods Ingredients Introduces Revolutionary Whey Protein
Nestlé Health Science Rolls Out SpikeRight® PLUS for Enteral Safety
Claris Receives USFDA Approval for Marketing Products in the US

5. RECENT INDUSTRY ACTIVITY
Nestlé Sets Up Health Science Manufacturing Plant
Fonterra to Buy Stake in Beingmate
Fonterra Collaborates with Beingmate to Meet Infant Formula Demand
Baxter Recalls Select Lots of Parenteral Nutrition Products
ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products
Unibrands and ICI to Market and Distribute Morinaga’s Infant Formula in Pakistan
Abbott Receives Approval for ENEVO™ Liquid for Enteral Use
Nestlé to Construct Infant Formula Plant in Mexico
Abbott Inaugurates Nutrition Production Facility in Haiti
Baxter Recalls Select Lots of Premix Parenteral Nutrition Products
Baxter Collaborates with JW Holdings for Omega 3 Lipids
Mead Johnson Establishes New Manufacturing and Research & Development Complex
Nestle Health Science Purchases Pamlab
Aspen Acquires IP Rights in Infant Nutritional Businesses of Nestlé
Danone Completes Acquisition of Wockhardt’s Nutrition Business
Abbott Nutrition Discontinues Enteral Device Business in the US and Puerto Rico
Danone Recalls Infant Formula Products in Asia
Yasheng Group Enters Joint Venture with IBC International LLC
Humana Establishes Offices in UAE
FDA Approves Clinolipid Lipid Injectable Emulsion
Nestle Acquires Pfizer Nutrition
Aperture Health Takes Over Triad Therapeutics
B Braun Acquires Nutrichem
Mead Johnson Nutrition Enters into Joint Venture with Sancor
Abbott Plans Collaboration with Syngene for Nutrition R&D Unit
AarhusKarlshamn Expands Capacity to Produce InFat™
Abbott to Construct Nutrition Production Facility in Ohio
BioGaia Enters into a Collaboration Agreement with Nestlé
Claris Lifesciences Enters into JV with Otsuka Pharma and Mitsui for Indian Market

6. FOCUS ON SELECT GLOBAL PLAYERS
Abbott Nutrition (US)
American HomePatient, Inc. (US)
Baxter International, Inc. (US)
B. Braun Melsungen AG (Germany)
Claris Lifesciences Ltd. (India)
Groupe Danone (France)
Nutricia North America (US)
Fresenius Kabi AG (Germany)
Hospira, Inc. (US)
Mead Johnson Nutrition Company (US)
Meiji Co., Ltd. (Japan)
Nestlé Health Science S.A (Switzerland)
Otsuka Pharmaceutical Factory, Inc. (Japan)
Sino-Swed Pharmaceutical Corp, Ltd. (China)

7. GLOBAL MARKET PERSPECTIVE
Table 51: World Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 52: World Historic Review for Clinical Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 53: World 14-Year Perspective for Clinical Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
Table 54: World Recent Past, Current and Future Analysis for Enteral Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 55: World Historic Review for Enteral Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 56: World 14-Year Perspective for Enteral Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
Table 57: World Recent Past, Current and Future Analysis for Infant Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 58: World Historic Review for Infant Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 59: World 14-Year Perspective for Infant Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
Table 60: World Recent Past, Current and Future Analysis for Parenteral Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 61: World Historic Review for Parenteral Nutrition Products by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 62: World 14-Year Perspective for Parenteral Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Market Overview
Rapidly Aging Demographics: A Major Driving Factor
Table 63: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Rising Incidences of Chronic Diseases Enhance Need for Clinical Nutrition Products
Cancer Statistics in the US
Table 64: New Cancer Cases in US by State: 2014
Table 65: New Cancer Cases in the US by Gender and Affected Site: 2014
Table 66: Cancer Related Deaths in the US by Gender and Body Site: 2014
Prevalence of Diabetes Mellitus in North America
Table 67: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
Table 68: North America Incidence of Type 1 Diabetes in Children (2012) (includes corresponding Graph/Chart)
An Insight into Infant Nutrition Market
Table 69: Baby & Toddler Nutrition Market in the US (2013): Percentage Share Breakdown of Value Sales by Segment (includes corresponding Graph/Chart)
Rising Number of Premature Births Augurs Well for Market Growth
Table 70: US Pre-term Birth Statistics (2012)
Strategic Innovations to Buoy Consumer Demand
Human Breast Milk-Like Infant Formulas to Gain Popularity
Competition
Table 71: Leading Players in the US Infant Formula Market (2013): Percentage Share Breakdown of Value Sales for Abbott, Mead Johnson, Nestle, and Others (includes corresponding Graph/Chart)
Table 72: Leading Infant Formula (Powder) Manufacturers in the US (2012): Percentage Share Breakdown of Value Sales* for Mead Johnson Nutrition Co, Abbott Nutrition, Nestlé Healthcare Nutrition, Gerber Products Co, Private Label and Others (includes corresponding Graph/Chart)
Table 73: Leading Infant Formula Brands in the US (2012): Percentage Share Breakdown of Value Sales* for Enfamil Premium, Similac Advance, Similac Sensitive, Enfamil Gentlease, Gerber Good Start Gentle Plus, Gerber Good Start Gentle, Similac Advance Early Shield, Private label and Others (includes corresponding Graph/Chart)
WIC Contract and the Infant Formula Rebate Program
WIC’s Infant Formula Rebate Program
Enteral Nutrition Market
Home Healthcare Fuels Demand for Home Enteral Nutrition Products
Enteral Nutrition Therapy to Treat Adult Malnutrition: Opportunities for Growth
Reimbursement Scenario for Enteral Nutrition Therapy
ENT Coverage under Part A
ENT Coverage under Part B
Reimbursements for Enteral Nutrients
Parenteral Nutrition Market: An Overview
Medicare Coverage for Parenteral Nutrition Therapy
Reimbursement Regulations to Hamper Market Growth
Shift towards Enteral Nutrition Therapies
A Threat to Parenteral Nutrition Market
Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
A.S.P.E.N. Practice Guidelines for Parenteral Nutrition
A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004)
Impact of Patient Protection and Affordable Care Act on IV Solutions Market
Product Launches
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 74: US Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 75: US Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 76: US 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Outlook
Rising Incidence of Chronic Diseases: A Major Growth Driver
Table 77: New Cancer Cases in Canada by Gender and Affected Site: 2014
Table 78: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart)
Table 79: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Table 80: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
Table 81: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart)
Table 82: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Table 83: Adult Diabetes Population by Age Group in Canada (2013) (In ‘000s) (includes corresponding Graph/Chart)
B.Market Analytics
Table 84: Canadian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 85: Canadian Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 86: Canadian 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Outlook
Rising Incidence of Chronic Diseases
A Prime Growth Driver
Table 87: Cancer Related Deaths by Age Groups: 2013
Table 88: Prevalence of Diabetes Mellitus in Japan (2013 & 2035) (includes corresponding Graph/Chart)
Product Launch
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 89: Japanese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 90: Japanese Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 91: Japanese 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Outlook
Debt Crisis in Europe Affects Healthcare Industry
Aging Population & Rising Incidence of Chronic Diseases to Drive Growth
Aging Statistics
Table 92: Population Breakup by Age Group for Select European Countries: 2012 (as a Percentage of Total Population) (includes corresponding Graph/Chart)
Cancer Trends
Table 93: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Prevalence of Diabetes Mellitus in Europe
Table 94: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
An Overview of Enteral Feeding Market in Europe
Prospering Enteral Nutrition Market: New Avenues for Ingredient Suppliers
Surging Interest in Home Healthcare: Gains for Enteral Nutrition Market
Infant Nutrition Market
Market Overview
The EC Directive on Infant Formulae and Follow-on Formulae
FSA’s Control on Infant Formulas and Follow-on Formula Advertisements
B.Market Analytics
Table 95: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 96: European Historic Review for Clinical Nutrition Products by Geographic Region
France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 97: European 14-Year Perspective for Clinical Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
Table 98: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 99: European Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 100: European 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Outlook
An Insight into the Market for Enteral Nutrition
Corporate Development
Groupe Danone
A Key Player
B.Market Analytics
Table 101: French Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 102: French Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 103: French 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Outlook
Entering Nutrition Market in Germany
An Overview
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 104: German Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 105: German Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 106: German 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 107: Italian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 108: Italian Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 109: Italian 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Outlook
Corporate Development
B.Market Analytics
Table 110: UK Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 111: UK Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 112: UK 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4e. SPAIN
Market Analysis
Table 113: Spanish Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 114: Spanish Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 115: Spanish 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4f. RUSSIA
Market Analysis
Table 116: Russian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 117: Russian Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 118: Russian 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A.Market Analysis
Outlook
Product Launches
Strategic Corporate Developments
Nestlé Health Science S.A (Switzerland)
A Key Player
B.Market Analytics
Table 119: Rest of Europe Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 120: Rest of Europe Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 121: Rest of Europe 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Outlook
Rising Diabetes Mellitus Cases in Asia-Pacific
Opportunity for Clinical Nutrition Companies
Table 122: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
Table 123: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
B.Market Analytics
Table 124: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 125: Asia-Pacific Historic Review for Clinical Nutrition Products by Geographic Region
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 126: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
Table 127: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020
Table 128: Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 129: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Outlook
Infant Formula Market: A Review
Table 130: Infant Formula Market in China (2013): Percentage Share Breakdown of Value Sales by Price Category (includes corresponding Graph/Chart)
Consolidation to Strengthen Infant Formula Industry
China Slaps Fines on Six Infant Formula Companies for Price-Fixing
Companies Lower Prices of Infant Formula Following Anti- Monopoly Probe
Key Challenges Facing Infant Formula Market
Rising Competition from Imported Products
Birth Rate
Need to Regain Consumer Confidence
Others
Competition
Table 131: Leading Players in the Chinese Infant Formula Market (2013): Percentage Share Breakdown of Value Sales for Abbott, Beingmate, Biostime, Danone, Daqing Dairy, Mead Johnson, Nestle, Yashili, and Others (includes corresponding Graph/Chart)
Parenteral Nutrition Market: An Insight
Enteral Nutrition Preparations Market: Competitive Landscape
Table 132: Leading Suppliers of Enteral Nutrition Preparations in China (2012): Percentage Share Breakdown of Value Sales for NUTRICIA (China), Sino-Swed Pharmaceutical Corp. Ltd, Novartis, Xi`an LIBANG Pharmaceutical Co, Ltd and Others (includes corresponding Graph/Chart)
Strategic Corporate Developments
Key Player
B.Market Analytics
Table 133: Chinese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 134: Chinese Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 135: Chinese 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
5b. INDIA
A.Market Analysis
Outlook
Ready-to-Use Therapeutic Food to Treat Severe Acute Malnutrition in India
Table 136: Percentage Share Breakdown of Cost Composition of Ingredients Required for the Production of RUTF (includes corresponding Graph/Chart)
Strategic Corporate Developments
Key Player
B.Market Analytics
Table 137: Indian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 138: Indian Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 139: Indian 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A.Market Analysis
Outlook
Australia: Home Enteral Nutrition in New South Wales
Product Launch
Strategic Corporate Developments
B.Market Analytics
Table 140: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 141: Rest of Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 142: Rest of Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST/AFRICA
A.Market Analysis
Outlook
Increasing Incidence of Chronic Conditions: Positive Growth Prospects
Table 143: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
Table 144: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
Corporate Development
B.Market Analytics
Table 145: Middle East/Africa Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 146: Middle East/Africa Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 147: Middle East/Africa 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA
A.Market Analysis
Outlook
Rising Incidence of Diabetes in Latin America
Opportunity Indicator
Table 148: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
B.Market Analytics
Table 149: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region
Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 150: Latin American Historic Review for Clinical Nutrition Products by Geographic Region
Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 151: Latin American 14-Year Perspective for Clinical Nutrition Products by Geographic Region
Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
Table 152: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 153: Latin American Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 154: Latin American 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
7a. BRAZIL
Market Analysis
Table 155: Brazilian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 156: Brazilian Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 157: Brazilian 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
7b. MEXICO
Market Analysis
Table 158: Mexican Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 159: Mexican Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 160: Mexican 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
7c. REST OF LATIN AMERICA
A.Market Analysis
Strategic Corporate Developments
B.Market Analytics
Table 161: Rest of Latin America Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 162: Rest of Latin America Historic Review for Clinical Nutrition Products by Product Type
Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 163: Rest of Latin America 14-Year Perspective for Clinical Nutrition Products by Product Type
Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 64 (including Divisions/Subsidiaries 88)
The United States (27)
Canada (1)
Japan (7)
Europe (27)
France (5)
Germany (4)
The United Kingdom (4)
Italy (1)
Spain (1)
Rest of Europe (12)
Asia-Pacific (Excluding Japan) (23)
Latin America (3)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Archer Daniels Midland Company Tate & Lyle, PLC. Comvita Natural Health Ltd. Danisco A/S Kerry Group Groupe Danone